{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:35:22Z","timestamp":1792100122825,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG069425"],"award-info":[{"award-number":["RF1AG069425"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG069425"],"award-info":[{"award-number":["RF1AG069425"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG069425"],"award-info":[{"award-number":["RF1AG069425"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY024984-S1"],"award-info":[{"award-number":["R01EY024984-S1"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["G2022014S"],"award-info":[{"award-number":["G2022014S"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of A\u03b2 plaques and neurofibrillary tangles, resulting in synaptic loss and neurodegeneration. The retina is an extension of the central nervous system within the eye, sharing many structural similarities with the brain, and previous studies have observed AD-related phenotypes within the retina. Three-dimensional retinal organoids differentiated from human pluripotent stem cells (hPSCs) can effectively model some of the earliest manifestations of disease states, yet early AD-associated phenotypes have not yet been examined. Thus, the current study focused upon the differentiation of hPSCs into retinal organoids for the analysis of early AD-associated alterations. Results demonstrated the robust differentiation of retinal organoids from both familial AD and unaffected control cell lines, with familial AD retinal organoids exhibiting a significant increase in the A\u03b242:A\u03b240 ratio as well as phosphorylated Tau protein, characteristic of AD pathology. Further, transcriptional analyses demonstrated the differential expression of many genes and cellular pathways, including those associated with synaptic dysfunction. Taken together, the current study demonstrates the ability of retinal organoids to serve as a powerful model for the identification of some of the earliest retinal alterations associated with AD.<\/jats:p>","DOI":"10.1038\/s41598-023-40382-4","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:03:10Z","timestamp":1692871390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Development of a three-dimensional organoid model to explore early retinal phenotypes associated with Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Sailee S.","family":"Lavekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Harkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1tia","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Chieh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta S.","family":"Puntambekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce T.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"40382_CR1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/alz.12638","volume":"18","author":"J Gaugler","year":"2022","unstructured":"Gaugler, J. et al. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 18, 700\u2013789. https:\/\/doi.org\/10.1002\/alz.12638 (2022).","journal-title":"Alzheimers Dement."},{"key":"40382_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/s0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow, K., de Leon, M. J. & Zetterberg, H. Alzheimer\u2019s disease. Lancet 368, 387\u2013403. https:\/\/doi.org\/10.1016\/s0140-6736(06)69113-7 (2006).","journal-title":"Lancet"},{"key":"40382_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/s0079-6123(08)64021-2","volume":"117","author":"H Braak","year":"1998","unstructured":"Braak, H., de Vos, R. A., Jansen, E. N., Bratzke, H. & Braak, E. Neuropathological hallmarks of Alzheimer\u2019s and Parkinson\u2019s diseases. Prog .Brain Res. 117, 267\u2013285. https:\/\/doi.org\/10.1016\/s0079-6123(08)64021-2 (1998).","journal-title":"Prog .Brain Res."},{"key":"40382_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ncb1104-1054","volume":"6","author":"DJ Selkoe","year":"2004","unstructured":"Selkoe, D. J. Cell biology of protein misfolding: The examples of Alzheimer\u2019s and Parkinson\u2019s diseases. Nat. Cell Biol. 6, 1054\u20131061. https:\/\/doi.org\/10.1038\/ncb1104-1054 (2004).","journal-title":"Nat. Cell Biol."},{"key":"40382_CR5","doi-asserted-by":"publisher","first-page":"104976","DOI":"10.1016\/j.nbd.2020.104976","volume":"143","author":"SM Neuner","year":"2020","unstructured":"Neuner, S. M., Tcw, J. & Goate, A. M. Genetic architecture of Alzheimer\u2019s disease. Neurobiol. Dis. 143, 104976. https:\/\/doi.org\/10.1016\/j.nbd.2020.104976 (2020).","journal-title":"Neurobiol. Dis."},{"key":"40382_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.biopsych.2017.05.014","volume":"83","author":"AA Pimenova","year":"2018","unstructured":"Pimenova, A. A., Raj, T. & Goate, A. M. Untangling genetic risk for Alzheimer\u2019s disease. Biol. Psychiatr. 83, 300\u2013310. https:\/\/doi.org\/10.1016\/j.biopsych.2017.05.014 (2018).","journal-title":"Biol. Psychiatr."},{"key":"40382_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/jad-179901","volume":"64","author":"J Cummings","year":"2018","unstructured":"Cummings, J., Ritter, A. & Zhong, K. Clinical trials for disease-modifying therapies in Alzheimer\u2019s disease: A primer, lessons learned, and a blueprint for the future. J. Alzheimers Dis. 64, S3-s22. https:\/\/doi.org\/10.3233\/jad-179901 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"40382_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40478-014-0079-9","volume":"2","author":"AFN Rosenberger","year":"2014","unstructured":"Rosenberger, A. F. N. et al. Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer\u2019s disease correlates with pathology. Acta Neuropathol. Commun. 2, 79. https:\/\/doi.org\/10.1186\/s40478-014-0079-9 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"40382_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","volume":"16","author":"GB Frisoni","year":"2017","unstructured":"Frisoni, G. B. et al. Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers. Lancet Neurol. 16, 661\u2013676. https:\/\/doi.org\/10.1016\/S1474-4422(17)30159-X (2017).","journal-title":"Lancet Neurol."},{"key":"40382_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/dnnd.S228939","volume":"9","author":"J Rasmussen","year":"2019","unstructured":"Rasmussen, J. & Langerman, H. Alzheimer\u2019s disease\u2014why we need early diagnosis. Degener. Neurol. Neuromuscul. Dis. 9, 123\u2013130. https:\/\/doi.org\/10.2147\/dnnd.S228939 (2019).","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"40382_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/nmt.14.19","volume":"4","author":"MH Dehabadi","year":"2014","unstructured":"Dehabadi, M. H., Davis, B. M., Wong, T. K. & Cordeiro, M. F. Retinal manifestations of Alzheimer\u2019s disease. Neurodegener. Dis. Manag. 4, 241\u2013252. https:\/\/doi.org\/10.2217\/nmt.14.19 (2014).","journal-title":"Neurodegener. Dis. Manag."},{"key":"40382_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3233\/jad-132105","volume":"40","author":"S Krantic","year":"2014","unstructured":"Krantic, S. & Torriglia, A. Retina: Source of the earliest biomarkers for Alzheimer\u2019s disease?. J. Alzheimers Dis. 40, 237\u2013243. https:\/\/doi.org\/10.3233\/jad-132105 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"40382_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London, A., Benhar, I. & Schwartz, M. The retina as a window to the brain-from eye research to CNS disorders. Nat. Rev. Neurol. 9, 44\u201353. https:\/\/doi.org\/10.1038\/nrneurol.2012.227 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"40382_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/nejm198608213150804","volume":"315","author":"DR Hinton","year":"1986","unstructured":"Hinton, D. R., Sadun, A. A., Blanks, J. C. & Miller, C. A. Optic-nerve degeneration in Alzheimer\u2019s disease. N. Engl. J. Med. 315, 485\u2013487. https:\/\/doi.org\/10.1056\/nejm198608213150804 (1986).","journal-title":"N. Engl. J. Med."},{"key":"40382_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/0006-8993(89)90653-7","volume":"501","author":"JC Blanks","year":"1989","unstructured":"Blanks, J. C., Hinton, D. R., Sadun, A. A. & Miller, C. A. Retinal ganglion cell degeneration in Alzheimer\u2019s disease. Brain Res. 501, 364\u2013372. https:\/\/doi.org\/10.1016\/0006-8993(89)90653-7 (1989).","journal-title":"Brain Res."},{"key":"40382_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1600-0420.1996.tb00090.x","volume":"74","author":"TR Hedges 3rd","year":"1996","unstructured":"Hedges, T. R. 3rd. et al. Retinal nerve fiber layer abnormalities in Alzheimer\u2019s disease. Acta Ophthalmol. Scand. 74, 271\u2013275. https:\/\/doi.org\/10.1111\/j.1600-0420.1996.tb00090.x (1996).","journal-title":"Acta Ophthalmol. Scand."},{"key":"40382_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0161-6420(90)32621-0","volume":"97","author":"AA Sadun","year":"1990","unstructured":"Sadun, A. A. & Bassi, C. J. Optic nerve damage in Alzheimer\u2019s disease. Ophthalmology 97, 9\u201317. https:\/\/doi.org\/10.1016\/s0161-6420(90)32621-0 (1990).","journal-title":"Ophthalmology"},{"key":"40382_CR18","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1136\/jnnp-2011-301628","volume":"83","author":"MK Ikram","year":"2012","unstructured":"Ikram, M. K., Cheung, C. Y., Wong, T. Y. & Chen, C. P. L. H. Retinal pathology as biomarker for cognitive impairment and Alzheimer\u2019s disease. J. Neurol. Neurosurg. Psychiatr. 83, 917\u2013922. https:\/\/doi.org\/10.1136\/jnnp-2011-301628 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"40382_CR19","doi-asserted-by":"publisher","first-page":"117022","DOI":"10.1016\/j.neuroimage.2020.117022","volume":"219","author":"D Bissig","year":"2020","unstructured":"Bissig, D., Zhou, C. G., Le, V. & Bernard, J. T. Optical coherence tomography reveals light-dependent retinal responses in Alzheimer\u2019s disease. Neuroimage 219, 117022. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.117022 (2020).","journal-title":"Neuroimage"},{"key":"40382_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1212\/01.wnl.0000280584.64363.83","volume":"69","author":"DA Valenti","year":"2007","unstructured":"Valenti, D. A. Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography. Neurology 69, 1060\u20131060. https:\/\/doi.org\/10.1212\/01.wnl.0000280584.64363.83 (2007).","journal-title":"Neurology"},{"key":"40382_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s11357-011-9260-2","volume":"34","author":"K Chiu","year":"2012","unstructured":"Chiu, K. et al. Neurodegeneration of the retina in mouse models of Alzheimer\u2019s disease: What can we learn from the retina?. Age 34, 633\u2013649 (2012).","journal-title":"Age"},{"key":"40382_CR22","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1007\/s12035-018-1461-6","volume":"56","author":"S Chiquita","year":"2019","unstructured":"Chiquita, S. et al. The retina as a window or mirror of the brain changes detected in Alzheimer\u2019s disease: Critical aspects to unravel. Mol. Neurobiol. 56, 5416\u20135435 (2019).","journal-title":"Mol. Neurobiol."},{"key":"40382_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mcn.2015.11.010","volume":"73","author":"AE Mungenast","year":"2016","unstructured":"Mungenast, A. E., Siegert, S. & Tsai, L. H. Modeling Alzheimer\u2019s disease with human induced pluripotent stem (iPS) cells. Mol. Cell Neurosci. 73, 13\u201331. https:\/\/doi.org\/10.1016\/j.mcn.2015.11.010 (2016).","journal-title":"Mol. Cell Neurosci."},{"key":"40382_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-32871-8","volume":"8","author":"CM Fligor","year":"2018","unstructured":"Fligor, C. M. et al. Three-dimensional retinal organoids facilitate the investigation of retinal ganglion cell development, organization and neurite outgrowth from human pluripotent stem cells. Sci. Rep. 8, 1\u201314 (2018).","journal-title":"Sci. Rep."},{"key":"40382_CR25","doi-asserted-by":"publisher","DOI":"10.1242\/dev.171686","author":"EE Capowski","year":"2019","unstructured":"Capowski, E. E. et al. Reproducibility and staging of 3D human retinal organoids across multiple pluripotent stem cell lines. Development https:\/\/doi.org\/10.1242\/dev.171686 (2019).","journal-title":"Development"},{"key":"40382_CR26","doi-asserted-by":"publisher","first-page":"764725","DOI":"10.3389\/fcell.2021.764725","volume":"9","author":"KJ Wahlin","year":"2021","unstructured":"Wahlin, K. J. et al. CRISPR generated SIX6 and POU4F2 reporters allow identification of brain and optic transcriptional differences in human psc-derived organoids. Front. Cell Dev. Biol. 9, 764725. https:\/\/doi.org\/10.3389\/fcell.2021.764725 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"40382_CR27","doi-asserted-by":"publisher","first-page":"100918","DOI":"10.1016\/j.preteyeres.2020.100918","volume":"83","author":"NK Mullin","year":"2021","unstructured":"Mullin, N. K. et al. Patient derived stem cells for discovery and validation of novel pathogenic variants in inherited retinal disease. Prog. Retin. Eye Res. 83, 100918. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100918 (2021).","journal-title":"Prog. Retin. Eye Res."},{"key":"40382_CR28","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/stem.674","volume":"29","author":"JS Meyer","year":"2011","unstructured":"Meyer, J. S. et al. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 29, 1206\u20131218. https:\/\/doi.org\/10.1002\/stem.674 (2011).","journal-title":"Stem Cells"},{"key":"40382_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6348","author":"KC Eldred","year":"2018","unstructured":"Eldred, K. C. et al. Thyroid hormone signaling specifies cone subtypes in human retinal organoids. Science https:\/\/doi.org\/10.1126\/science.aau6348 (2018).","journal-title":"Science"},{"key":"40382_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5966\/sctm.2015-0093","volume":"5","author":"A Sridhar","year":"2016","unstructured":"Sridhar, A., Ohlemacher, S. K., Langer, K. B. & Meyer, J. S. Robust differentiation of mRNA-reprogrammed human induced pluripotent stem cells toward a retinal lineage. Stem Cells Transl. Med. 5, 417\u2013426. https:\/\/doi.org\/10.5966\/sctm.2015-0093 (2016).","journal-title":"Stem Cells Transl. Med."},{"key":"40382_CR31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel, M. A. et al. Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature 482, 216\u2013220. https:\/\/doi.org\/10.1038\/nature10821 (2012).","journal-title":"Nature"},{"key":"40382_CR32","doi-asserted-by":"crossref","unstructured":"Fligor, C. M., Huang, K.-C., Lavekar, S. S., VanderWall, K. B. & Meyer, J. S. in Methods in Cell Biology Vol. 159 279\u2013302 (Elsevier, 2020).","DOI":"10.1016\/bs.mcb.2020.02.005"},{"key":"40382_CR33","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.stemcr.2022.05.006","volume":"17","author":"C Gomes","year":"2022","unstructured":"Gomes, C. et al. Astrocytes modulate neurodegenerative phenotypes associated with glaucoma in OPTN(E50K) human stem cell-derived retinal ganglion cells. Stem Cell Rep. 17, 1636\u20131649. https:\/\/doi.org\/10.1016\/j.stemcr.2022.05.006 (2022).","journal-title":"Stem Cell Rep."},{"key":"40382_CR34","doi-asserted-by":"publisher","first-page":"16698","DOI":"10.1073\/pnas.0905245106","volume":"106","author":"JS Meyer","year":"2009","unstructured":"Meyer, J. S. et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc. Natl. Acad. Sci. 106, 16698\u201316703 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"40382_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/9780470151808.sc01h08s32","author":"SK Ohlemacher","year":"2015","unstructured":"Ohlemacher, S. K., Iglesias, C. L., Sridhar, A., Gamm, D. M. & Meyer, J. S. Generation of highly enriched populations of optic vesicle-like retinal cells from human pluripotent stem cells. Curr. Protoc. Stem Cell Bio. https:\/\/doi.org\/10.1002\/9780470151808.sc01h08s32 (2015).","journal-title":"Curr. Protoc. Stem Cell Bio."},{"key":"40382_CR36","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/stem.2356","volume":"34","author":"SK Ohlemacher","year":"2016","unstructured":"Ohlemacher, S. K. et al. Stepwise differentiation of retinal ganglion cells from human pluripotent stem cells enables analysis of glaucomatous neurodegeneration. Stem Cells 34, 1553\u20131562. https:\/\/doi.org\/10.1002\/stem.2356 (2016).","journal-title":"Stem Cells"},{"key":"40382_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.stemcr.2020.05.009","volume":"15","author":"KB VanderWall","year":"2020","unstructured":"VanderWall, K. B. et al. Retinal ganglion cells with a glaucoma OPTN(E50K) mutation exhibit neurodegenerative phenotypes when derived from three-dimensional retinal organoids. Stem Cell Rep. 15, 52\u201366. https:\/\/doi.org\/10.1016\/j.stemcr.2020.05.009 (2020).","journal-title":"Stem Cell Rep."},{"key":"40382_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.stemcr.2018.12.010","volume":"12","author":"KB VanderWall","year":"2019","unstructured":"VanderWall, K. B. et al. Astrocytes regulate the development and maturation of retinal ganglion cells derived from human pluripotent stem cells. Stem Cell Rep. 12, 201\u2013212. https:\/\/doi.org\/10.1016\/j.stemcr.2018.12.010 (2019).","journal-title":"Stem Cell Rep."},{"key":"40382_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41419-018-0740-5","volume":"9","author":"A Grimaldi","year":"2018","unstructured":"Grimaldi, A. et al. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer\u2019s disease in the 3xTg-AD mouse model. Cell Death Dis. 9, 685. https:\/\/doi.org\/10.1038\/s41419-018-0740-5 (2018).","journal-title":"Cell Death Dis."},{"key":"40382_CR40","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fnins.2019.00925","volume":"13","author":"A Grimaldi","year":"2019","unstructured":"Grimaldi, A. et al. Neuroinflammatory processes, A1 astrocyte activation and protein aggregation in the retina of Alzheimer\u2019s disease patients, possible biomarkers for early diagnosis. Front. Neurosci. 13, 925 (2019).","journal-title":"Front. Neurosci."},{"key":"40382_CR41","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/jamaneurol.2014.2482","volume":"71","author":"Q Liu","year":"2014","unstructured":"Liu, Q. et al. Effect of potent \u03b3-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers. JAMA Neurol. 71, 1481\u20131489. https:\/\/doi.org\/10.1001\/jamaneurol.2014.2482 (2014).","journal-title":"JAMA Neurol."},{"key":"40382_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.stem.2018.12.013","volume":"24","author":"R van der Kant","year":"2019","unstructured":"van der Kant, R. et al. Cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-\u03b2 in iPSC-derived Alzheimer\u2019s disease neurons. Cell Stem Cell 24, 363-375.e369. https:\/\/doi.org\/10.1016\/j.stem.2018.12.013 (2019).","journal-title":"Cell Stem Cell"},{"key":"40382_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93621","author":"Y Koronyo","year":"2017","unstructured":"Koronyo, Y. et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.93621 (2017).","journal-title":"JCI Insight"},{"key":"40382_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London, A., Benhar, I. & Schwartz, M. The retina as a window to the brain\u2014from eye research to CNS disorders. Nat. Rev. Neurol. 9, 44\u201353. https:\/\/doi.org\/10.1038\/nrneurol.2012.227 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"40382_CR45","doi-asserted-by":"publisher","first-page":"e0232785","DOI":"10.1371\/journal.pone.0232785","volume":"15","author":"S Asanad","year":"2020","unstructured":"Asanad, S. et al. Retinal nerve fiber layer thickness predicts CSF amyloid\/tau before cognitive decline. PLoS ONE 15, e0232785. https:\/\/doi.org\/10.1371\/journal.pone.0232785 (2020).","journal-title":"PLoS ONE"},{"key":"40382_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-017-0199-3","volume":"12","author":"M Chiasseu","year":"2017","unstructured":"Chiasseu, M. et al. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer\u2019s disease. Mol. Neurodegener. 12, 58. https:\/\/doi.org\/10.1186\/s13024-017-0199-3 (2017).","journal-title":"Mol. Neurodegener."},{"key":"40382_CR47","first-page":"2600","volume":"34","author":"KU Loeffler","year":"1993","unstructured":"Loeffler, K. U., Edward, D. P. & Tso, M. O. Tau-2 immunoreactivity of corpora amylacea in the human retina and optic nerve. Invest Ophthalmol. Vis. Sci. 34, 2600\u20132603 (1993).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"40382_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.exer.2017.09.013","volume":"165","author":"A Aboelnour","year":"2017","unstructured":"Aboelnour, A., Van der Spuy, J., Powner, M. & Jeffery, G. Primate retinal cones express phosphorylated tau associated with neuronal degeneration yet survive in old age. Exp. Eye Res. 165, 105\u2013108. https:\/\/doi.org\/10.1016\/j.exer.2017.09.013 (2017).","journal-title":"Exp. Eye Res."},{"key":"40382_CR49","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.bbadis.2013.05.021","volume":"1549\u20131559","author":"A Yamazaki","year":"1832","unstructured":"Yamazaki, A. et al. Microtubule-associated protein tau in bovine retinal photoreceptor rod outer segments: Comparison with brain tau. Biochim. Biophys. Acta 1549\u20131559, 2013. https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.021 (1832).","journal-title":"Biochim. Biophys. Acta"},{"key":"40382_CR50","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin, Y. T. et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1141-1154.e1147. https:\/\/doi.org\/10.1016\/j.neuron.2018.05.008 (2018).","journal-title":"Neuron"},{"key":"40382_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-022-00545-9","volume":"17","author":"SS Puntambekar","year":"2022","unstructured":"Puntambekar, S. S. et al. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u2019s disease. Mol. Neurodegener. 17, 47. https:\/\/doi.org\/10.1186\/s13024-022-00545-9 (2022).","journal-title":"Mol. Neurodegener."},{"key":"40382_CR52","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.1523\/jneurosci.1056-19.2019","volume":"39","author":"SH Krance","year":"2019","unstructured":"Krance, S. H., Cogo-Moreira, H., Rabin, J. S., Black, S. E. & Swardfager, W. Reciprocal predictive relationships between amyloid and tau biomarkers in Alzheimer\u2019s disease progression: An empirical model. J. Neurosci. 39, 7428\u20137437. https:\/\/doi.org\/10.1523\/jneurosci.1056-19.2019 (2019).","journal-title":"J. Neurosci."},{"key":"40382_CR53","doi-asserted-by":"publisher","first-page":"e0276933","DOI":"10.1371\/journal.pone.0276933","volume":"17","author":"DV Zaretsky","year":"2022","unstructured":"Zaretsky, D. V., Zaretskaia, M. V. & Molkov, Y. I. Patients with Alzheimer\u2019s disease have an increased removal rate of soluble beta-amyloid-42. PLoS ONE 17, e0276933. https:\/\/doi.org\/10.1371\/journal.pone.0276933 (2022).","journal-title":"PLoS ONE"},{"key":"40382_CR54","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1523\/jneurosci.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor, P. N. et al. A\u03b2 oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. J. Neurosci. 27, 796\u2013807. https:\/\/doi.org\/10.1523\/jneurosci.3501-06.2007 (2007).","journal-title":"J. Neurosci."},{"key":"40382_CR55","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/brain\/awaa395","volume":"144","author":"JB Pereira","year":"2020","unstructured":"Pereira, J. B. et al. Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer\u2019s disease. Brain 144, 310\u2013324. https:\/\/doi.org\/10.1093\/brain\/awaa395 (2020).","journal-title":"Brain"},{"key":"40382_CR56","doi-asserted-by":"publisher","first-page":"1129036","DOI":"10.3389\/fnsyn.2023.1129036","volume":"15","author":"S Meftah","year":"2023","unstructured":"Meftah, S. & Gan, J. Alzheimer\u2019s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression. Front. Synaptic. Neurosci. 15, 1129036. https:\/\/doi.org\/10.3389\/fnsyn.2023.1129036 (2023).","journal-title":"Front. Synaptic. Neurosci."},{"key":"40382_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.01.006","author":"FJ Rodriguez-Jimenez","year":"2023","unstructured":"Rodriguez-Jimenez, F. J., Ure\u00f1a-Peralta, J., Jendelova, P. & Erceg, S. Alzheimer\u2019s disease and synapse Loss: What can we learn from induced pluripotent stem cells?. J. Adv. Res. https:\/\/doi.org\/10.1016\/j.jare.2023.01.006 (2023).","journal-title":"J. Adv. Res."},{"key":"40382_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/jad-220983","volume":"92","author":"N Samudra","year":"2023","unstructured":"Samudra, N., Ranasinghe, K., Kirsch, H., Rankin, K. & Miller, B. Etiology and clinical significance of network hyperexcitability in Alzheimer\u2019s disease: Unanswered questions and next steps. J. Alzheimers Dis. 92, 13\u201327. https:\/\/doi.org\/10.3233\/jad-220983 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"40382_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00074","author":"L Younes","year":"2019","unstructured":"Younes, L. et al. Identifying changepoints in biomarkers during the preclinical phase of Alzheimer\u2019s disease. Front. Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2019.00074 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"40382_CR60","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/alz.12577","volume":"18","author":"C Claes","year":"2022","unstructured":"Claes, C. et al. The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer\u2019s disease mouse model. Alzheimers Dement. 18, 1765\u20131778. https:\/\/doi.org\/10.1002\/alz.12577 (2022).","journal-title":"Alzheimers Dement."},{"key":"40382_CR61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13073-022-01022-0","volume":"14","author":"AP Tsai","year":"2022","unstructured":"Tsai, A. P. et al. PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u2019s disease. Genome Med. 14, 17. https:\/\/doi.org\/10.1186\/s13073-022-01022-0 (2022).","journal-title":"Genome Med."},{"key":"40382_CR62","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3233\/JAD-200492","volume":"77","author":"S Fung","year":"2020","unstructured":"Fung, S. et al. Early-onset familial Alzheimer disease variant PSEN2 N141I heterozygosity is associated with altered microglia phenotype. J. Alzheimers Dis. 77, 675\u2013688 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"40382_CR63","doi-asserted-by":"publisher","first-page":"eabl7634","DOI":"10.1126\/scitranslmed.abl7634","volume":"14","author":"M Moutinho","year":"2022","unstructured":"Moutinho, M. et al. The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer\u2019s disease. Sci. Transl. Med. 14, eabl7634. https:\/\/doi.org\/10.1126\/scitranslmed.abl7634 (2022).","journal-title":"Sci. Transl. Med."},{"key":"40382_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-018-0297-x","volume":"13","author":"A McQuade","year":"2018","unstructured":"McQuade, A. et al. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol. Neurodegener. 13, 67. https:\/\/doi.org\/10.1186\/s13024-018-0297-x (2018).","journal-title":"Mol. Neurodegener."},{"key":"40382_CR65","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud, E. M. et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278-293.e279. https:\/\/doi.org\/10.1016\/j.neuron.2017.03.042 (2017).","journal-title":"Neuron"},{"key":"40382_CR66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-021-00473-0","volume":"16","author":"C Claes","year":"2021","unstructured":"Claes, C. et al. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u2019s disease. Mol. Neurodegener. 16, 50. https:\/\/doi.org\/10.1186\/s13024-021-00473-0 (2021).","journal-title":"Mol. Neurodegener."},{"key":"40382_CR67","first-page":"119","volume":"2","author":"FR Kreitzer","year":"2013","unstructured":"Kreitzer, F. R. et al. A robust method to derive functional neural crest cells from human pluripotent stem cells. Am. J. Stem Cells 2, 119\u2013131 (2013).","journal-title":"Am. J. Stem Cells"},{"key":"40382_CR68","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145\u20131147. https:\/\/doi.org\/10.1126\/science.282.5391.1145 (1998).","journal-title":"Science"},{"key":"40382_CR69","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5966\/sctm.2012-0101","volume":"2","author":"A Sridhar","year":"2013","unstructured":"Sridhar, A., Steward, M. M. & Meyer, J. S. Nonxenogeneic growth and retinal differentiation of human induced pluripotent stem cells. Stem Cells Transl. Med. 2, 255\u2013264. https:\/\/doi.org\/10.5966\/sctm.2012-0101 (2013).","journal-title":"Stem Cells Transl. Med."},{"key":"40382_CR70","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucl. Acids Res. 44, W90-97. https:\/\/doi.org\/10.1093\/nar\/gkw377 (2016).","journal-title":"Nucl. Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40382-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40382-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40382-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T22:03:10Z","timestamp":1700344990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40382-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40382"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40382-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"3 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13827"}}